Mastercard Incorporated vs. OptimizeRx Corporation Common Stock
Mastercard Incorporated and OptimizeRx Corporation Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| MA | OPRX | |
|---|---|---|
| Market Cap | $502.70 billion | $149.93 million |
| Revenue (TTM) | $35.08 billion | — |
| Net Income (TTM) | $16.26 billion | — |
MA leads on 1 of 1 size & scale factors.
Valuation
| MA | OPRX | |
|---|---|---|
| P/E Ratio | 31.94 | — |
| Price / Book | 89.67 | — |
| Price / Sales | 14.33 | — |
MA and OPRX split the valuation factors evenly.
Profitability
| MA | OPRX | |
|---|---|---|
| Net Margin | 46.34% | — |
| Return on Equity | 289.99% | — |
MA and OPRX split the profitability factors evenly.
Dividend
| MA | OPRX | |
|---|---|---|
| Dividend Yield | 0.60% | — |
| Payout Ratio | 19.14 | — |
MA and OPRX split the dividend factors evenly.
Risk & Sentiment
| MA | OPRX | |
|---|---|---|
| Short Interest | 0.73% | 0.00% |
OPRX leads on 1 of 1 risk & sentiment factors.
Dig deeper: MA overview, MA financials, OPRX overview, OPRX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.